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The clerodane diterpene casearin J induces apoptosis
of T-ALL cells through SERCA inhibition, oxidative
stress, and interference with Notch1 signaling
C De Ford1,2,3, B Heidersdorf3, F Haun2,4, R Murillo5, T Friedrich2,6, C Borner2,4,7 and I Merfort*,1,2,3
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy that preferentially affects children and
adolescents. Over 50% of human T-ALLs possess activating mutations of Notch1. The clerodane diterpene casearin J (CJ) is a
natural product that inhibits the sarcoendoplasmatic reticulum calcium ATPase (SERCA) pump and induces cell death in leukemia
cells, but the molecular mechanism of cytotoxicity remains poorly understood. Here we show that owing to SERCA pump
inhibition, CJ induces depletion of the endoplasmic reticulum calcium pools, oxidative stress, and apoptosis via the intrinsic
signaling pathway. Moreover, Notch1 signaling is reduced in T-ALL cells with auto-activating mutations in the HD-domain of
Notch1, but not in cells that do not depend on Notch1 signaling. CJ also provoked a slight activation of NF-κB, and consistent with
this notion a combined treatment of CJ and the NF-κB inhibitor parthenolide (Pt) led to a remarkable synergistic cell death in T-ALL
cells. Altogether, our data support the concept that inhibition of the SERCA pump may be a novel strategy for the treatment of
T-ALL with HD-domain-mutant Notch1 receptors and that additional treatment with the NF-κB inhibitor parthenolide may have
further therapeutic benefits.
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T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive
hematologic cancer resulting from the malignant transforma-
tion of T-cell progenitors that preferentially develops in children
and adolescents but is also commonly found in adults. More
than 50% of human T-ALLs show auto-activation of Notch1
signaling that is responsible for the oncogenic transformation
of T cells and for the impaired apoptosis and enhanced
survival mechanisms of this malignancy.1–4 Notch1 belongs to
a family of conserved single transmembrane receptors that are
crucial for the control of differentiation, proliferation, and
apoptosis in T cells and other types of cells.5,6 The canonical
Notch signaling pathway is activated through a series of
proteolytic cleavages (S1–S3). S1 cleavage is carried out by a
Furin-like convertase in the trans-Golgi apparatus. Subse-
quently, the resulting heterodimeric receptor is transported to
the membrane where it binds to Delta-Serrate-LAG or Jagged
ligands from a neighboring cell. Notch1 is then cleaved by
ADAM family metalloproteases (S2) and γ-secretase (S3)
resulting in the release of the Notch1 intracellular domain
(NICD), which translocates to the nucleus to promote
transcription of target genes involved in cell growth.6–9 The
most frequent Notch1 mutations are observed in the hetero-
dimerization (HD) and PEST domains.1,2 Mutations of the HD
domain allow a ligand-independent activation of the NICD
promoting the uncontrolled growth of T-ALL cells.10
Although new chemotherapeutic protocols have improved
the prognosis of T-ALL, the outcome of patients with resistant
or relapsed leukemia remains poor,1,11 highlighting the need
for more effective antileukemic drugs.9 The identification of
somatic activating Notch1 mutations in the majority of T-ALLs
has stimulated interest in targeting the Notch1-signaling
pathway. However, γ-secretase inhibitors induced only little
apoptosis in human T-ALL,12 and exhibited strong cytotoxic
effects in the gastrointestinal tract owing to inhibiting both
mutant and wild-type Notch, thus limiting the use of this
approach for cancer therapy as single agents.13,14 By
contrast, a recent report from Roti et al. showed that small
molecule inhibitors of the sarcoendoplasmatic reticulum
calcium ATPase (SERCA pump) are capable of preferentially
inhibit mutant Notch1 activation, without gastrointestinal side-
effects.15
Casearin J (CJ; Figure 1a) is a tricyclic clerodane diterpene
found in Casearia sylvestris, a plant from the Salicaceae
family. We have previously reported that representatives of
this class of secondary plant metabolites are preferentially
cytotoxic to leukemia cells16 and that they directly inhibit
the SERCA pump.17 However, the exact mechanism of
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cytotoxicity and the reason for their preference toward
leukemia cells remain poorly understood. Here, we addressed
these issues in T-ALL cells exhibiting mutations in the
HD-domain of Notch1 (CCRF-CEM), a doxorubicin-resistant
version of these cells (CEM-ADR5000), and Jurkat cells that
possess extracellular juxtamembrane expansion mutations of
Notch1.18 As a consequence of SERCA pump inhibition,
CJ induces calcium release from the endoplasmic reticulum
Figure 1 Casearin J (CJ) modulates calcium homeostasis and oxidative stress in T-ALL cells. (a) Structural formula of CJ. (b) CJ-induced instant calcium release of T-ALL
cells measured with the Fluo-4 calcium probe. The calcium curves represent an average of three independent experiments. (c) Reduction of CJ-induced calcium release by
pretreatment with an IP3R (2-aminophenylborate, 2-APB) or a CRAC channel inhibitor (YM-58483). The calcium curve for CJ is given again in this graph to compare the effects
with the inhibitors. (d) Induction of oxidative stress in T-ALL cells after 24 h of incubation with CJ quantified by DCF fluorescence. As concentrations, the respective IC50 values of
CJ were used (CCRF-CEM cells: 0.7 μM; CEM-ADR5000 cells: 2.3 μM; Jurkat cells: 2.5 μM). The data are presented as mean±S.D. (n= 3) and statistically analyzed by two-
way ANOVA and Bonferroni’s post hoc test. *Po0.05; **Po0.01; ***Po0.001
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(ER), promoting an increase in reactive oxygen species (ROS)
and apoptosis of T-ALL cells. In addition, CJ reduces the levels
of NICD and hence the mRNA levels of its target genes in
T-ALL cells, which have HD-domain mutations in Notch1, but
not in Jurkat cells. Furthermore, synergistic effects in cell
death were observed with parthenolide (Pt), an NF-κB
inhibitor. Altogether, our data corroborate the notion that
inhibition of the SERCA pump may be a novel strategy for the
treatment of HD-domain-mutant Notch1 T-ALL and that an
additional treatment with the NF-κB inhibitor Pt may have
further therapeutic benefits.
Results
CJ triggers depletion of ER Ca2+ pool in T-ALL cells and
activates store-operated calcium entry. To determine the
effect of CJ-induced SERCA pump inhibition on the
ER-calcium depletion, we examined intracellular Ca2+ levels
([Ca2+]c) of T-ALL cells. Addition of CJ to CCRF-CEM cells in
the presence of extracellular Ca2+ provoked a rapid,
concentration-dependent biphasic increase in [Ca2+]c reach-
ing a Ca2+ peak and then descending to a sustained plateau
above basal levels (Figure 1b). The same was observed in
Jurkat cells. Thapsigargin (Tg), a known potent SERCA
pump inhibitor, elicited a similar Ca2+ response but with a
higher Ca2+ release at 1 μM. On the contrary, CEM-ADR5000
cells, which are resistant to doxorubicin, released less
calcium upon stimulation with Tg or CJ. This result is in line
with reports showing that chemotherapy-resistant cancer
cells can overexpress P-glycoprotein and possess a
dysregulated calcium homeostasis, promoting resistance to
SERCA pump inhibitors.19,20
To confirm that inositol 1,4,5-triphosphate receptors
(IP3Rs) were the source of the increase in [Ca
2+]c, we
pretreated the cells with 30 μM 2-APB, an IP3R inhibitor.
2-aminoethoxydiphenyl borate (2-APB) pretreatment consid-
erably prevented the increase of [Ca2+]c (Figure 1c), suggest-
ing that CJ induced ER Ca2+ pool depletion through these
channels. It is known that exhaustion of the intracellular Ca2+
stores provokes a Ca2+ entry mechanism through the calcium
release-activated calcium (CRAC) channel, so-called
store-operated calcium entry.21 We therefore pretreated
CCRF-CEM cells with 10 μM of the CRAC channel inhibitor
YM-58483. As shown in Figure 1c, this inhibitor provoked a
smaller Ca2+ transient and prevented the induced Ca2+ influx
through CRAC channels, returning the [Ca2+]c back to basal
levels. Altogether, these data demonstrate that CJ is able to
modulate the calcium homeostasis of T-ALL cells.
CJ-induced deregulation of calcium homeostasis
promotes oxidative stress. Emptying of the intracellular
Ca2+ stores results in a Ca2+ overload in mitochondria and
hyperoxidation of the ER, which then causes cellular
oxidative stress.22,23 We therefore measured the generation
of ROS by the conversion of DCFH2-DA to fluorescent
dichlorofluorescein (DCF) after a 24 h incubation with CJ. Tg
was used as a positive control for calcium-induced ROS. As
shown in Figure 1d, in all three cell lines, CJ induced a
concentration-dependent and statistically significant increase
in DCF fluorescence, which was completely reversible by
pretreatment with N-acetylcysteine (NAC). Notably, an
increase in ROS production was also observed with CJ but
not with Tg in CEM-ADR5000 cells, although this cell line
shows resistance to SERCA pump inhibitors, indicating
another mechanism independent of ER Ca2+ release, in
these chemoresistant cells.
Previous studies have shown that mitochondria can buffer
excess calcium released from IP3R through the mitochondrial
calcium uniporter (mCU).24,25 To study the impact of the IP3R
andmCUonROSproduction, T-ALL cells were pretreated with
2-APB or with the mCU inhibitor KB-R7943.26 CCRF-CEM
and Jurkat cells treated with 2-APB showed a complete
inhibition of CJ-induced ROS, whereas CEM-ADR5000 only
exhibited a small but significant decrease. In addition,
KB-R7943 was able to substantially decrease the ROS levels
in all the three cell lines tested (Figure 1d), indicating that
calcium influx into the mitochondria has a major role in the
production of oxidative stress in T-ALL cells. To investigate
whether CJ directly induces ROS production through inhibition
of the respiratory chain, isolated beef heart mitochondria were
treated with CJ. No inhibition was observed up to a
concentration of 100 μM of CJ (data not shown), suggesting
that calcium release from the ER, and not a direct action of CJ
on mitochondria is responsible for the induction of the ROS
production.
CJ prompts cell death of T-ALL cells by disrupting
intracellular Ca2+ homeostasis. Next, we determined
whether SERCA pump inhibition by CJ had any effect on
cell survival. We previously reported potent cytotoxic effects
of CJ in CCRF-CEM cells (IC50= 0.7 μM).
17 Continuing these
studies, we now assessed the viability of other T-ALL cells
(CEM-ADR5000 and Jurkat cells) as well as CD3+ cells from
healthy human donors after 24 h of CJ treatment using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. As shown in Figure 2a and b, CJ was able to
induce cell death in T-ALL cells in the low micromolar
concentration range. CCRF-CEM cells were more suscep-
tible to cell death than CEM-ADR5000 and Jurkat cells
(Figure 2a). Although CJ was also cytotoxic to normal CD3+
cells isolated from human blood, T-ALL cells were signifi-
cantly more susceptible to SERCA pump inhibition when
comparing IC50 values (Po0.01). For example, although
1.25 μM CJ reduced the cell viability of CCRF-CEM cells by
82%, the same concentration reduced cell survival of CD3+
cells by 14% (Figure 2a). In addition, CJ was tested in the
NCI-60 panel of cell lines showing an overall preferential
cytotoxicity to leukemia cells (Figure 2b). Interestingly,
CJ promoted strong growth inhibition (GI) at 1 μM in leukemia
cells with dysregulated Notch signaling, whereas this effect
was significantly less in cells with normal Notch alleles
(Figure 2c).
To study the impact of Ca2+ release from the ER on cell
viability, we pretreated the T-ALL cells with the IP3R inhibitor 2-
APB. In agreement with the results from our calcium release
assay, inhibition of IP3R prevented CJ-induced cell death in
CCRF-CEM and to a lesser extent in Jurkat cells but not in
CEM-ADR5000 (Figure 2d). Also NAC was able to protect
the cells from CJ-induced cell death, suggesting that oxidative
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stresswas amediator of cell death induced by calcium release
in T-ALL cells. To determine whether the reduced cell viability
was due to apoptosis cells were pretreated with QVD-OPh, a
pancaspase inhibitor,27 before CJ was added and cell death
measured by MTT. QVD-OPh was able to partially restore
the cell viability in CCRF-CEM and Jurkat cells, suggesting
that apoptosis is involved in cell death. Surprisingly, the
doxorubicin-resistant CEM-ADR5000 cells showed only a
slight effect with QVD-OPh. This is in line with reports that
caspase inhibitors promote alternative cell death pathways
and that drug-resistant cells are more prone to necrosis upon
cytotoxic drugs when caspases are inhibited.28,29
CJ induces the intrinsic mitochondrial signaling pathway
in T-ALL. Treatment of cells with cytotoxic drugs can initiate
intrinsic apoptosis. We therefore measured the activation of
procaspase-9 (the apical caspase of the intrinsic apoptotic
pathway) and its target, effector caspases-3/-7. T-ALL cells
treated with CJ showed a concentration-dependent proces-
sing/activation of procaspase-9 that is reversed by blocking
oxidative stress (Figure 3a) in all three cells lines, but only
partially prevented by inhibiting the IP3Rs. CCRF-CEM cells
showed the best response to the IP3R inhibitor, as shown by
the quantification of the immunoblots, correlating with the
previous results. Similarly, CJ caused a dose-dependent
activation of caspase-3/-7, which was markedly inhibited by
2-APB, NAC and QVD-OPh in CCRF-CEM, and Jurkat cells.
Again no effect was observed with 2-APB in CEM-ADR5000
(Figure 3b). Caspase-3/-7 activation leads to DNA degrada-
tion, one of the hallmarks of apoptosis. Therefore,
fluorescence-activated cell sorting (FACS) analyses were
carried out to quantify the increase in sub-G1 DNA-containing
Figure 2 Effects of CJ on cell viability of T-ALL and CD3+ cells. (a) Cell viability curves were obtained with the MTTassay after 24 h of incubation. The IC50 value of CJ in
CCRF-CEM cells was previously obtained.17 The data are presented as mean±S.D. (n= 3), the IC50 values were calculated by non-linear regression. (b) Growth inhibition (GI)
of CJ tested with the sulphorodamine assay in the NCI-60 panel of human cancer cell lines. (c) Comparison of the GI of CJ at 1 μM in cells with dysregulated Notch signaling
(CCRF-CEM, MOLT-4, HL-60) versus cells with normal Notch (K-562, RPMI-8226, SR), **Po0.01. (d) Characterization of the mechanism of cytotoxicity using the reactive
oxygen species (ROS) scavenger N-acetylcysteine (NAC), the IP3R blocker 2-APB, and the caspase inhibitor QVD-OPh. Concentrations indicate the respective IC50 values of CJ
(see figure legend 1). Data are expressed as mean± S.D. (n= 3) and statistically analyzed by two-way ANOVA and Bonferroni’s post hoc test. *Po0.05; **Po0.01; ***Po0.001
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cells. In accordance with the caspase-3/-7 assay, CJ-treated
T-ALL cells showed increased levels of hypodiploid DNA
(sub-G1) in a concentration-dependent manner. This
increase was prevented by pretreating CCRF-CEM with
QVD-OPh, NAC, or 2-APB (Figure 3c). Jurkat and
CEM-ADR5000 cells showed a different behavior although
2-APB was not able to restore the CJ-induced sub-G1
population in these cell lines as much as in CCRF-CEM cells.
We wanted to confirm the sub-G1 data by measuring
cytoplasmic histone-associated DNA fragmentation using the
Cell Death Detection ELISA kit (Roche). In the three cell lines
tested CJ was able to induce DNA degradation (Figure 3d).
CJ-induced degradation of CCRF-CEM cells was largely
diminished, albeit not totally prevented by NAC and 2-APB. To
determinewhether CJ-treated cells also underwent secondary
apoptosis or necrosis we quantified the release of lactate
dehydrogenase (LDH) from cells with damaged cell
membranes. A dose-dependent increase in LDH was noted
in all three cell lines (Figure 3e). Interestingly, the strongest
LDH release was seen in Jurkat and CEM-ADR5000 and
much less in the CCRF-CEM. On the other hand, 2-APB, NAC,
and QVD primarily prevented LDH release in CCRF-CEM cell
line, but only partially in Jurkat and CEM-ADR5000 cells.
These results indicate that apart from apoptosis, CJ also
induces uncontrolled necrosis, but with different impact from
calcium release or oxidative stress in different cell lines.
Altogether, our data demonstrate that CJ-induced SERCA
pump inhibition, followed by IP3R-mediated Ca
2+ release and
Figure 3 CJ induces apoptosis in T-ALL cells. (a) Proteolytic processing/activation of procaspase-9 (PC-9) after 24 h of incubation (n= 2) as shown by the disappearance of
the inactive pro-form of caspase-9. A representative immunoblot is shown. Quantification of the immunoblots was performed with Image J taking the ratio of PC-9/GAPDH of the
negative control as 1. NAC: 1 mM. 2-APB: 30 μM. Tg: 1 μM. (b) Caspase-3/-7 activation measured as DEVDase enzymatic activity. Cpt: camptothecin. (c) Quantification of the
sub-G1 population of T-ALL cells stained with propidium iodide as a measure of DNA degradation by FACS. (d) Histone-associated DNA fragments detected by ELISA. (e)
Membrane integrity assay for the detection of lactate dehydrogenase release to the extracellular space. Concentrations indicate the respective IC50 values of CJ (see figure
legend 1). All experiments were carried out after 24 h of incubation with CJ. The data are presented as mean± S.D. (n= 3) and statistically analyzed by two-way ANOVA and
Bonferroni’s post hoc test. **Po0.01; ***Po0.001
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oxidative stress induces apoptotic cell death in CCRF-CEM
cells as well as other cell death mechanisms in the resistant
CEM-ADR5000 and Jurkat cells.
Inhibition of the SERCA pump by CJ influences mutant
Notch1 signaling. The apparent preference of CJ toward
T-ALL cells with dysregulated Notch1 signaling prompted us
to study how CJ may influence Notch1. We first determined
whether Notch1 was still transported to the membrane
surface after stimulation of the cells with CJ. As shown in
Figure 4a, the surface expression of Notch1 was significantly
reduced in CCRF-CEM and CEM-ADR5000 cells in a
concentration-dependent manner with only small changes
in Jurkat cells (Figure 4a). Moreover, inhibition of ER-calcium
release through the IP3Rs completely restored surface
expression of Notch1 after stimulation with CJ in
CCRF-CEM cells, but not in CEM-ADR5000 cells. Notably,
in the presence of NAC, Notch1 was also maintained on the
cell surface of CCRF-CEM and CEM-ADR5000 (Figure 4a).
These data suggest that inhibition of SERCA pump with
subsequent release of calcium and ROS production leads to
a preferential inhibition of Notch exocytosis and signaling
when it is mutated in the HD-domain.
Notch1 is processed by furin, which is a vital step in the
maturation process and occurs at the S1 cleavage site in the
Golgi apparatus (Figure 4b).1 To analyze the impact of CJ on
this maturation step, protein extracts of CJ-treated T-ALL
cell lines were immunoblotted to detect the Notch1
furin-processed transmembrane subunit (NTM, 120 kDa). CJ
reduced the levels of NTM in a concentration-dependent
manner in CCRF-CEM cells, whereas no effect was observed
in CEM-ADR5000 or Jurkat cells (Figure 4c). Interestingly,
only 2-APB was able to recover the expression of NTM,
indicating that calcium release is responsible for this effect.
Moreover, HD-domain-mutant Notch1 is auto-activated
once it reached the membrane in two cleavage steps
(S2 and S3) (Figure 4b). To study if reduced expression of
Notch1 at the surface correlates with lower levels of NICD,
immunoblotting was performed. As expected, NICD levels
were reduced after CJ treatment in a concentration-dependent
manner (Figure 4c) and this was again prevented by 2-APB or
NAC (Figure 4c), being in line with the FACS results. NICD
levels were also strongly reduced by CJ in CEM-ADR5000
cells, but in contrast to CCRF-CEM cells, the inhibitors were
not able to recover the basal levels of NICD, suggesting a
different mechanism of inhibition. Jurkat cells showed no
decrease of NICD or NTM levels after SERCA pump inhibition
(Figure 4c).
Once NICD is released from the membrane, it translocates
to the nucleus and activates its target genes (e.g., MYC,
HES1). We therefore performed quantitative real-time PCR of
a series of NICD target genes after 6 h of CJ treatment. Low
micromolar concentrations of CJ significantly reduced the
expression of MYC and HES1 in CCRF-CEM and CEM-
ADR5000 cells. On the contrary, no effect was observed in
Jurkat cells (Figure 4d), supporting the immunoblotting and
FACS results.
To further clarify the role of Notch1 in the mechanism
of cytotoxicity of CJ in CCRF-CEM cells, NICD was
overexpressed by transducing cells with an empty pBABE
vector or with pBABE-NICD (Figure 4e, left panel). Cell
viability studies demonstrated that CCRF-CEM cells are
protected from CJ-induced cell death when a non-inhibitable
NICD is overexpressed. This effect is absent with the empty
pBABE vector (Figure 4e, right panel).
CJ synergizes with the NF-κB inhibitor Pt. NF-κB activa-
tion by ER stress requires both an increase in intracellular
levels of Ca2+ and ROS.30 CJ caused the emptying of the
ER-calcium stores and oxidative stress in T-ALL cells. There-
fore, we studied whether treatment of cells with CJ had an
impact on the activation of NF-κB. Electrophoretic mobility shift
assay (EMSA) analysis showed a slight increase in NF-κB
DNA binding in CJ-treated CCRF-CEM cells (Figure 5a).
These observations prompted us to evaluate whether T-ALL
cells were more susceptible to a dual inhibition of the SERCA
pump and NF-κB. Targeting the NF-κB pathway in Notch1
mutant T-ALL cells has already been proposed,4,15 but the
combination of an NF-κB and a SERCA pump inhibitor has not
been reported so far. We therefore used Pt (Figure 5b), a
natural compound, known to inhibit NF-κB and to readily
induce apoptosis in cancer cells.31,32
First, the IC50 values of Pt in the three cell lines were
determined (Figure 5c). Subsequently, the three cell lineswere
pretreated for 1 h with a low cytotoxic concentration of
Pt (2.5 μM) and increasing concentrations of CJ for 24 h. Pt
alone had no effect on NF-κB DNA binding but it prevented
the CJ-induced NF-κB activation (Figure 5a). Moreover,
CJ-induced NF-κB DNA binding was slightly reduced by
pretreating the cells with NAC and 2-APB (Figure 5a).
Interestingly, the combined treatment caused a rapid decline
in the cell viability of CCRF-CEM and CEM-ADR5000 cells as
shown by the MTT assay (Figure 5d). The synergistic effect
was observed at the lowest tested concentrations of CJ except
for Jurkat cells. Accordingly, similar synergistic effects were
also observed in the apoptosis assays (Figure 5e and f). To get
further insights in the synergistic effects, cell surface expres-
sion of Notch1 was studied under the dual treatment of T-ALL
cells. As shown in Figure 5g, Pt alone is unable to modulate
the expression of Notch1 receptors at the surface of the
membrane, but the combination resulted in a slight, but
statistical significant decrease as compared with CJ alone, an
effect that may contribute to the synergistic effect of apoptosis
induction in Notch1 mutant cells.
Discussion
Membrane proteins, such as Notch receptors, are folded and
processed in the ER/Golgi apparatus before being displayed
on the cell surface.6,33,34 Maturation of Notch receptors
requires the proteolytic cleavage by a furin-like protease at
the S1 cleavage site. A non-covalently bonded heterodimer is
formed consisting of the ligand-binding extracellular domain
(NEC) and the transmembrane domain (NTM; Figure 4b).
Calcium is required for the proper folding and the structural
integrity of this heterodimer.35–37 The ER is the most important
intracellular Ca2+ store.38 Regulation of intracellular Ca2+ by
the ER is mainly mediated by the SERCA pump, which
shuttles Ca2+ from the cytosol into the ER. Therefore, SERCA
pump inhibitors, such as the sesquiterpene lactone Tg, have
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Figure 4 CJ preferentially influences mutant Notch1 signaling in T-ALL cells. (a) Cell surface expression of Notch1 receptors quantified by FACS analysis after treatment of
the cells with CJ alone or after pretreatment with the IP3R inhibitor 2-APB or NAC; a representative experiment is shown on the left panel. (b) Schematic assembly of the Notch1
receptor. (c) Immunoblotting of Notch1 transmembrane region (NTM) and Notch1 intracellular domain (NICD) after treatment of the cells with CJ alone or after pretreatment with
2-APB or NAC. A representative immunoblot is shown. (d) qRT-PCR to determine the mRNA expression level of the Notch1 target genesMYC and HES1. Concentrations indicate
the respective IC50 values of CJ (see Figure legend 1). (e) Immunoblot of NICD in pBABE-NICD-transduced CCRF-CEM cells (left panel, n= 2; a representative blot is shown)
and cell viability experiments of the empty vector and the NICD-transduced cells treated with CJ (right panel). All experiments were carried out after 24 h of incubation with CJ.
Data are presented as mean± S.D. (n= 3) and statistically analyzed by two-way ANOVA and Bonferroni’s post hoc test. *Po0.05; **Po0.01; ***Po0.001
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been described to intervene in the maturation process of
Notch1 receptors and to be strong inductors of apoptosis in
HD-domain-mutant T-ALL cells.15
We here demonstrate that natural tricyclic clerodane
diterpenes, such as CJ, can also affect the Notch1-signaling
pathway in human T-ALL cells. We show for the first time that
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CJ is able to induce ER-calcium depletion through the IP3R as
a direct consequence of SERCA pump inhibition. This effect
in turn provokes mitochondria to buffer the excess cytosolic
calcium through mCU and to induce the generation of
mitochondrial ROS. Mitochondrial matrix Ca2+ overload
triggers cytochrome c release, caspase-9, and -3 activation,
and leads to apoptosis.39,40 Our results revealed that
CJ-induced apoptosis, measured as caspase-9 and
caspase-3/-7 activation and DNA degradation, was more
pronounced in non-resistant Notch1 HD-mutant cells than in
leukemia cells with extracellular juxtamembrane mutations in
Notch1. Apoptosis was dependent on calcium release from
the IP3Rs and oxidative stress, corroborating a pivotal role of
these two responses in the mechanism of action of this natural
product. Doxorubicin-resistant T-ALL cells exhibited a certain
resistance to SERCA pump inhibition, and therefore calcium
release through IP3Rs did not have a major role in the
mechanism of CJ-induced apoptosis. In contrast, Jurkat cells
seemed to exert a different mechanism of cell death. Besides
of apoptosis, necrosis was also observed in this cell line,
suggesting that in the absence of Notch1 mutations in the
HD-domain CJ may induce other effects, which are not related
to this transcription factor.
Altogether, our results indicate that Notch1 has an important
role in the cytotoxic mechanism of CJ as the compound
reduced the furin processing of Notch1, cell surface expres-
sion of Notch1 receptors, and prevented the formation of the
cleaved NICD-signaling molecule. These effects were pre-
ferentially visible in T-ALL cells with HD-domain mutations of
Notch1, but not in cells that do not depend on Notch1
signaling. In addition, overexpression of NICD protects CCRF-
CEM cells from CJ-induced cell death. This is in line with
studies from Roti et al.15 They have shown that SERCA pump
inhibition by Tg preferentially prevents the maturation of
mutant Notch1, whereas normal receptors are still expressed.
In addition, we provide evidence that the increase in oxidative
stress may also contribute to this effect. High amounts of
calcium-induced ROS prevented the expression of the
receptors on the cell surface and consequently the auto-
activation of NICD. Owing to ER-calcium release, unfolded
and misfolded proteins, such as mutant Notch1, could
accumulate in the ER lumen leading to the activation of the
unfolded protein response (UPR), ROS production, and
apoptosis.34,41 The interplay between misfolded proteins in
the ER, oxidative stress, activation of UPR, and apoptosis has
recently been reported.42 This scenario could explain the
observed cell death induced by CJ and why the IP3R receptor
inhibitor 2-APB and the antioxidant NAC were so effective in
blocking this cell death in T-ALL cells.
NICD, the maturation product derived from Notch1, is a
transcription factor regulating the expression of genes, such as
MYC or HES1. Myc is an oncogenic transcription factor that
controls cell growth and metabolism. Therefore, the aberrant cell
proliferation and increased survival of T-ALL are partly controlled
by the Notch1-Myc transcriptional network.43 The Notch1-Hes1
regulatory axis is implicated in the upregulation of PI3K and NF-
κBsignaling aswell as in the inhibition of apoptosis by repressing
the proapoptotic BH3-only protein Puma.44 We could demon-
strate that CJ was also able to downregulate the Notch1 target
genesMYC and HES1, which may contribute to the induction of
apoptosis. Taken together, our results indicate that the CJ-
induced repression of mutant Notch1 re-activates the apoptotic
machinery in T-ALL cells and strengthen the rationale for the use
of SERCA inhibitors in the treatment of Notch1 mutant T-ALL,
and probably of those cancers with mutant Notch1. This
proposed mechanism is depicted in Figure 6.
Constitutively active Notch1 activates NF-κB by directly
stimulating the IKK signalosome.45,46 Inhibition of this pathway
can efficiently prevent tumor growth in vitro and in vivo.4,47
Accordingly, the combination of CJ and the NF-κB inhibitor
Pt synergistically reduced cell viability and enhanced apopto-
sis in HD-domain-mutant T-ALL cells, either resistant to
doxorubicin or not. In agreement with Vilimas et al.,4 we were
unable to observe synergistic effects in Jurkat cells, which are
known to bemore resistant to NF-κB inhibition4 and insensitive
to γ-secretase inhibitors treatment.5 The combination of Pt and
CJ had a stronger impact on the cell surface expression of
HD-domain-mutant Notch1 receptors than the single com-
pounds alone, indicating the involvement of auto-activated
Notch1 in the synergism. Summarizing our results and
considering the well-known function of NF-κB in the control
of cell survival, we propose that a dual inhibition of SERCA
pump and NF-κB could be a novel promising approach to treat
T-ALL in the future. However, further work is needed to validate
the combined therapy in in vivo tumor models.
Materials and Methods
Cell lines and reagents. CCRF-CEM and CEM-ADR5000 cells were obtained
as a gift from Professor T Efferth, Department of Pharmaceutical Biology, Johannes
Gutenberg University, Mainz, Germany. Jurkat cells were obtained from ATCC (clone
E6-1, ATCC TIB-152). All T-ALL cell lines were cultured in RPMI 1640 (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum,
penicillin (100 U/ml), and streptomycin (100 μg/ml) at 37 °C under 5% CO2. Antibodies
to procaspase-9 (catalog #9502), NTM (#4380) and NICD (catalog #2421 and #4147)
were from New England Biolabs (Frankfurt, Germany), and to GAPDH from Merck-
Millipore (Darmstadt, Germany) (MAB374, clone 6C5). For flow cytometry, antibodies to
Notch1 receptor and isotype control were obtained from BD Bioscience (San Jose, CA,
USA) (clone MHN-519 and P3.6.2.8.1, respectively). The following inhibitors were used:
2-APB, YM-58483, KB-R7943, and Pt from Sigma-Aldrich (Darmstadt, Germany), NAC
from Roth, and QVD-OPh from MP Biomedicals (Heidelberg, Germany).
Figure 5 Synergistic inhibitory effects of CJ in combination with parthenolide (Pt). Cells were pretreated for 1 h with Pt and then with different concentrations of CJ for 24 h.
Concentrations of CJ indicate its IC50 value in CCRF-CEM cells (0.7 μM). (a) EMSA showing NF-κB DNA binding after treating CCRF-CEM cells with CJ alone or together with Pt
(2.5 μM). TNF: tumor necrosis factor-α (4 ng/ml). NAC (1 mM). 2-APB (30 μM). The arrowhead indicates the position of NF-κB DNA complexes. The circle denotes a non-
specific activity binding to the probe. One representative EMSA is shown. (b) Structural formula of Pt. (c) Cell viability curves of T-ALL cells with Pt after 24 h of incubation using
the MTTassay. (d) Cell viability of the three cell lines after single and dual treatment of CJ and Pt using the MTTassay. (e) Quantification of the sub-G1 population of T-ALL cells
stained with propidium iodide as a measure of DNA degradation by FACS analysis after single and combined treatment. Cpt: camptothecin. (f) Histone-associated DNA fragments
detected by ELISA. (g) Notch1 cell surface expression in T-ALL cells after single and dual treatment. Data are presented as mean± S.D. (n= 3) and statistically analyzed by one-
way ANOVA (a) or two-way ANOVA (d–g) and Bonferroni’s post hoc test. *Po0.05; **Po0.01; ***Po0.001
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Isolation of CD3+ cells from human blood. CD3+ cells were isolated by
using human CD3 microbeads (MACS, Miltenyi Biotec, Bergisch Gladbach,
Germany) according to the manufacturer´s protocol. In brief, PBMCs were first
isolated from human buffy coats of healthy donors (ethical permission number from
the ethics commission, University of Freiburg: 356/13; 2013) by using a density-
gradient medium (LymphoPrep). Isolated PBMCs were immediately incubated with
CD3 microbeads for 15 min at 4 °C and separated using a magnetic column. CD3+
cells were obtained and immediately used after separation. RPMI medium was used
for the incubation of the cells.
Calcium release. Cytosolic calcium in T-ALL cells was monitored using a
Fluo-4 direct calcium assay kit (Thermo Fisher Scientific, Langenseibold, Germany)
according to the manufacturer’s protocol. 1.5 × 105 cells were seeded in 96-well
plates and incubated with Fluo-4-AM for 30 min at 37 °C and 5% CO2 and
subsequently 30 min at room temperature. After incubation, the cells were washed
with PBS and 100 μl of assay buffer were added to each well. The [Ca2+]c was
monitored in real-time using a Varioskan Flash multimode reader (Thermo Fisher
Scientific) for a total of 300 s. A baseline of 50 s was measured prior to addition of
CJ. Tg was used as positive control for ER-calcium depletion. Cells were pretreated
with inhibitor molecules 1 h prior to treatment with CJ.
Measurement of intracellular ROS formation. The dye 2´,7´-dichloro-
fluorescin diacetate (DCFH-DA), which is oxidized to the DCF by hydroperoxides,
was used to measure relative levels of cellular peroxides as previously described.48
In brief, 2 × 106 T-ALL cells were seeded into six-well plates and incubated with
different concentrations of CJ for 24 h. In case of the use of an inhibitor, cells were
stimulated 1 h with the inhibitor prior to treatment with CJ. The cells were
centrifuged and washed with PBS and incubated with RPMI medium containing
20 μM DCFH-DA for 30 min in the dark. Subsequently, cells were washed with PBS,
resuspended in RPMI medium and the fluorescence was measured at an excitation
wavelength of 485 nm and an emission wavelength of 530 nm using a microplate
fluorescence reader. Protein quantification by Bradford assay was done to normalize
the values.
Measurement of ROS in bovine heart mitochondria. Superoxide
dismutates rapidly to H2O2. Thus, the total rate of superoxide and H2O2 production
was measured by the horseradish peroxidase-dependent oxidation of Amplex
Red.49 The 1 ml assay contained 50 μg bovine heart mitochondrial membranes,
2 U horseradish peroxidase and 10 μM Amplex Red. The reaction was started by
the addition of 30 μM NADH in the presence of 10 μM piericidin. When indicated,
1-100 μM CJ were added. The oxidation of the nucleotide was followed at 340 nm;
the production of resorufin was monitored at 557 minus 620 nm (ε= 23.1/mM/cm at
pH 6.0) using an UV/vis diode array photometer (J&M; Aalen, Germany).
Cell viability. MTTassay was carried out for quantitative analysis of cell viability
as previously described.16 In brief, cells were seeded in 96-well plates and
Figure 6 Notch 1 signaling pathway and proposed mechanism of action of CJ. Notch is synthesized in the ER as pre-Notch. After the maturation process, Notch1 is
transported by vesicle trafficking to the plasma membrane where it is activated, releasing NICD. HD-domain mutations induce a ligand-independent activation of Notch1. NICD
translocates to the nucleus to promote transcription of target genes such asMYC, HES1, IL2R, NFKB2, BCL-2, and NOTCH1 itself. NICD also activates NF-κB. Thus, modulation
of the cell cycle, differentiation, and inhibition of apoptosis takes place in a cooperative mechanism when Notch1 and NF-κB are involved in T-ALL. CJ-induced SERCA pump
inhibition induces calcium release through the IP3R, which is buffered by mitochondria through the mCU channel, inducing a mitochondrial calcium overload followed by an
induction of oxidative stress. This ER stress impairs signaling of the oncogenic mutant Notch1 and activates the intrinsic apoptotic pathway and finally cell death of T-ALL cells.
Notably, a combination of SERCA pump and NF-κB inhibition shows synergistic effects in cell death
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incubated with CJ for 24 h at 37 °C and 5% CO2. In case of the use of an inhibitor,
cells were stimulated 1 h with the inhibitor prior to treatment with CJ. MTT solution
(5 mg/ml) was added to each well after the incubation period, and the absorbance
was measured at 595 nm after 2 h incubation by dissolving the formazan crystals
in DMSO. IC50 values were calculated by non-linear regression using
GraphPad Prism.
Tumor cell line profiling in the NCI-60 panel. Tumor cell line profiling
was performed by the National Cancer Institute (NCI) as part of the NCI-60 Human
Tumor Cell line Anticancer Drug Screen (http://dtp.nci.nih.gov). GI potential of
CJ was determined with the sulphorodamine assay in five different concentrations.
Caspase-3/7 activity. Cells were seeded in six-well plates at a density of
2 × 106 cells/well and incubated for 24 h with CJ at various concentrations. After the
incubation, cells were washed with PBS and resuspended in lysis buffer (31 mM
Hepes-KOH pH 7.4, 2.5 mM EGTA, 2.5 mM MgCl2, 12 mM DTT, 120 μM PMSF,
12 ng/ml leupeptin, 500 ng/ml pepstatin, 12 μg/ml aprotinin, 1.5 μg/ml cytochalasin
B). Three freeze–thaw cycles were carried out by freezing in liquid nitrogen and
thawing in a 40 °C water bath with subsequent vortexing. Protein extracts were
centrifuged at 20 800 × g and 4 °C for 10 min and the concentration was quanitifed
using the BSA kit (BioRad, München, Germany). The fluorescence emitted by the
release of 7-amino-4-methylcumarin (AMC) from the caspase-3/-7 substrate
(Ac-DEVD-AMC) was monitored in a Fluostar Optima plate reader with an excitation
wavelength of 370 nm and an emission wavelength of 450 nm. Relative
fluorescence unit (RFU) values were calculated via the ratio of average rate of
the fluorescence increase and protein concentration. RFU sample values were
referred to negative controls (untreated cells) and given as fold increase values.
Cell-cycle measurement by FACS. In total, 1 × 106 cells were seeded in
1 ml of culture medium in 12-well plates, incubated overnight, and exposed to CJ for
24 h. After exposure, cells were pelleted, washed with PBS, and fixed in 2 ml of ice
cold 70% ethanol and kept at 4 °C overnight. Afterwards, cells were centrifuged at
1500 rpm for 10 min and resuspended in PBS containing 0.1 mg/ml RNase and
0.25 mg/ml propidium iodide. The cells were incubated for 30 min at 37 °C and 5%
CO2 and the DNA content of cells was measured by a FACScalibur
(BD Biosciences). In total, 10 000 gated events were analyzed for each sample.
Cell death detection ELISA. Determination of cytoplasmic histone-
associated DNA fragments was determined spectrophotometrically at 405 nm
using the Cell Death Detection ELISA kit (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’s protocol. In brief, 1 × 106 cells were seeded in six-
well plates and incubated with CJ for 24 h. After the incubation period, the ELISA
was carried out. The enrichment factor was calculated by comparing the
absorbance units with the negative control.
LDH-release assay. LDH-release assay was carried out for the quantitative
determination of cytotoxicity owing to cell membrane permeabilization using the
Cytotoxicity Detection kit (LDH) (Roche Diagnostics) according to the manufac-
turer’s protocol. In brief, cells were seeded in six-well plates at a density of 2 × 106
cells/well in RPMI 1640 culture medium. After incubation, cells were treated with CJ
for 24 h. The absorbance was measured at 490 nm. Total LDH release (100%) was
obtained by the treatment of cells with 2% Triton-X. The relative LDH release is
defined by the ratio of LDH released over total LDH in the intact cells.
Notch1 cell surface staining. In total, 1 × 106 cells were seeded into
12-well plates and incubated for 24 h with CJ. Cells were harvested and washed
twice with a PBS buffer containing 0.5% bovine serum albumin and 0.02% sodium
azide. Each sample was treated separately with either Notch1 antibody or isotype
control antibody for 1 h. After the incubation period the cells were washed twice with
the washing buffer and subjected to FACS analysis using the FL4 channel.
Immunoblotting. In total, 2 × 106 cells were seeded into six-well plates in 2 ml
of culture medium and incubated for 24 h. After stimulation, cells were pelleted,
washed with PBS, resuspended in lysis buffer (HEPES 20 mM pH 7.9, NaCl
350 mM, glycerol 20%, NP-40 1%, MgCl2 2.5 mM, EDTA 0.5 mM, EGTA 2.5 mM,
DTT 12 mM, PMSF 125 μM, Aprotinin 12 μg/ml, Pepstatin 500 ng/ml, 12 μg/ml
aprotinin), and incubated at 4 °C for 30 min. Cell lysates containing equal amount of
protein were separated by SDS-PAGE, transferred to PVDF membranes and
immunoblotted with antibody against procaspase-9, NICD, or GAPDH.
Immunoreactive bands were detected with an ECL advanced chemiluminescence
detection reagent (Amersham Pharmacia Biotech, Pittsburgh, PA, USA).
Immunoblots were quantified using Image J (NIH).
RNA isolation, cDNA synthesis, and qRT-PCR. Total RNA from T-ALL
cells was isolated using the RNeasy Plus Mini Kit from Qiagen (Hilden, Germany)
and converted to single-strand cDNA using the QuantiTect Reverse Transcription Kit
from Qiagen according to the manufacturer’s protocol. The analysis of mRNA
expression profiles was performed with qRT-PCR. Primers and probes were
designed with Oligo Architect online v4.0 from Sigma-Aldrich. The data were
analyzed using the ΔΔCT method and plotted as percentage of transcript
compared with negative control. In a 25 μl PCR reaction, 2 μl of cDNA
(corresponding to 20 ng of total RNA input) was amplified in a LightCycler 480
using 2 × conc. LightCycler 480 Probes Master, 50 nM primers and 100 nM probe
for the 18 S rRNA reference gene (fwd: 5′-CGGCTACCACATCCAAGG-3′, rev:
5′-CGGGTCGGGAGTGGGT-3′, probe: 5′-[HEX]-TTGCGCGCCTGCTGCCT-[TAM]-3′)
or 300 nM primers and 100 nM probe for the gene of interest. The following target
gene primers and probes were used: human MYC fwd: 5′-CATGGTGAACCAGA
GTTTC-3′, rev: 5′-CAGTCCTGGATGATGATG-3′, probe: 5′-[6-FAM]-CGGACGACG
AGACCTTCATCA-[TAM]-3′. human HES1 fwd: 5′-GCTGATAACAGCGGAATC-3′,
rev: 5′-TGTGGCTACTTGGTGATC-3′, probe: 5′-[6-FAM]-TCTCCTTGGTCCTGG
AACAGC-[TAM]-3′.
Cloning of human NICD. EF.hNICD.CMV.GFP was a gift from Linzhao
Cheng (Addgene plasmid #17623) to clone human NICD into the retroviral
expression vector pBabe.puro. NICD was amplified by PCR to create BamHI (NICD-
BamHI-fwd: 5′-ATATGGATCCGCCACCATGCGGCGGCAGCATG-3′) and EcoRI
(NICD-EcoRI-rev: 5′-GAGAGAATTCTTACTTGAACGCCTCCGGG-3′) restriction
sites for subcloning in the pBABE vector.
Retroviral infection of NICD. Viral particles to infect CCRF-CEM cells were
produced in HEK 293 T cells. In total, 2 × 106 cells were seeded in 10-cm plates. On
the day of transfection, 3 μg of the plasmid pBABE.puro.hNICD or empty vector
(pBABE), 3 μg enveloping vector VSVg, and 3 μg packaging vector Hit60 were
adjusted to 300 ml in serum-/antibiotics free Opti-MEM Life Technologies (Darmstadt,
Germany) and gently mixed with 30 μl attractene transfection reagent (Qiagen). The
transfection mix was added to the cells for 6 h. Cells were then incubated for 8 h in
DMEM supplemented with 10% FCS, 1% Pen/Strep and 5 mM sodium butyrate
(Sigma, Taufkirchen, Germany). The virus were harvested from the supernatant, 5 μg/
ml polybrene (Sigma) was added to increase infection efficiency. Fresh supernatant
was then used for infection of 1 × 105 CCRF-CEM cells. Cells were resuspended in
400 μl virus supernatant. For spinfection, cells were plated in 12-well plates and
centrifuged at 2000 rpm for 10 min. After centrifugation, infected cells were incubated
for 1 h at 37 °C before supplementation with 1 ml full medium. Transfected cells and
cells with empty vector were used for the MTT assay as described above.
EMSA NF-κB. In total, 2 × 106 cells were seeded into six-well plates and
incubated for 24 h with CJ. Cells stimulated with human TNF-α (4 ng/ml) for 30 min
served as a positive control for NF-κB activation. After stimulation with CJ, cells were
pelleted, washed with PBS, and lysed in totex lysis buffer. In case of the use of an
inhibitor cells were stimulated 1 h with the inhibitor prior to treatment with CJ. The
Bradford protein assay (BioRad) was used to determine the concentration of the
protein extract. The EMSA was performed as previously described by Könczöl et al.50
Statistical analysis. Data are expressed as means± S.D. One-way ANOVA
or two-way ANOVA with Bonferroni´s post hoc test was used for the statistical
significances depending on the setting of the experiment. Results were considered
significant with Po0.05, Po0.01 very significant, and Po0.001 as highly
significant. Three independent experiments were carried out with all the above-
mentioned methods unless otherwise stated.
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